Machina Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

Machina Capital’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.22M	Sell	8,076 -890	-10%	-$456K	0.59%	37
2026 Q2	$4.45M	Sell	8,966 -688	-7%	-$305K	0.71%	38
2026 Q1	$4.31M	Buy	9,654 +4,590	+91%	+$2.14M	0.85%	17
2025 Q4	$2.3M	Sell	5,064 -6,103	-55%	-$2.63M	0.44%	76
2025 Q3	$4.37M	Buy	+11,167	New	+$4.67M	0.77%	30
2024 Q3	–	Sell	-2,117	Closed	-$992K	–	365
2024 Q2	$992K	Buy	2,117 +123	+6%	+$53.4K	0.45%	83
2024 Q1	$834K	Buy	+1,994	New	+$843K	0.44%	86
2023 Q4	–	Sell	-2,348	Closed	-$816K	–	361
2023 Q3	$816K	Buy	+2,348	New	+$821K	0.46%	83
2023 Q2	–	Sell	-900	Closed	-$284K	–	530
2023 Q1	$284K	Sell	900 -200	-18%	-$60K	0.25%	150
2022 Q4	$318K	Buy	+1,100	New	+$335K	0.59%	80
2020 Q1	–	Sell	-3,481	Closed	-$762K	–	294
2019 Q4	$762K	Sell	3,481 -1,251	-26%	-$253K	0.3%	133
2019 Q3	$802K	Sell	4,732 -743	-14%	-$131K	0.37%	98
2019 Q2	$1M	Sell	5,475 -9,172	-63%	-$1.6M	0.38%	90
2019 Q1	$2.69M	Buy	14,647 +13,780	+1,589%	+$2.55M	1.07%	9
2018 Q4	$144K	Buy	+867	New	+$150K	0.1%	225

Other funds holding VRTX

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $59.1B AUM 41.96% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Machina Capital's VRTX Position: Q3 2026 in Review

Machina Capital reduced its Vertex Pharmaceuticals (VRTX) stake by 9.9% in Q3 2026, selling an estimated $456K and leaving 8,076 shares worth $4.22M. The position accounts for 0.59% of the portfolio, ranked #37.

Machina Capital first reported a position in VRTX in Q4 2018 and has held it in 15 quarters since. The position peaked at $4.45M in Q2 2026. 1,161 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

Machina Capital held 8,076 shares of Vertex Pharmaceuticals worth $4.22M as of Q3 2026.
Machina Capital sold 890 Vertex Pharmaceuticals shares in Q3 2026, an estimated $456K.
Vertex Pharmaceuticals made up 0.59% of Machina Capital's portfolio in Q3 2026, its #37 holding.
Machina Capital first reported a position in Vertex Pharmaceuticals in Q4 2018 and has held it in 15 quarters since.
Machina Capital's Vertex Pharmaceuticals position peaked at $4.45M in Q2 2026.
1,161 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Machina Capital's 13F filing for Q3 2026, filed 5 Nov 2026.